Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIRWISE: Stiolto Respimat vs Triple Therapy in COPD
NCT03265145Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2017
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Sep 2017; status: completed.
02
Drugs
olodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03265145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03265145.